Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Belive so too
CERC is holding up very well today. Technical is playing a very big part in the share price.
Come on Technicals Let's see where you take Cerecor inc share price this week. Need to get back over $2.50 for some of us shareholders to have a very Merry Christmas.
Let's Go CERC !!
Come Technicals let's see where you takes Cerecor Inc share price this week. Let's CERC.
Let's take out the Ask all the way until after hours closing. Come on Longs and new buyers we can do it. Let's get the shorts covering in after hours. Hit that Ask real hard and they will cover.
Alright Longs it's time to take back our share price in the after hours market. Let's make these shorts cover and open high tomorrow.
Shareholders sometimes need to buy in After hours this how the share price goes up in after hours hit the Ask when it is low, and blocks are far in between. Can run pass $2.50 in after hours if Longs and new buyers will take out the Ask low blocks, and keep it moving. That will help make shorts cover in after hours.
Seem like shareholders are getting screw by Cerecor, no news, no updates, and lots of dumping.
OH BOY YOU SOUND LIKE ANOTHER ORCA
STICK TO PENNIES BRAH
YOU CANT MOVE BIG BOARD STOCKS
sold all +$2.50 go fir it
Takin' CERC up currently... like it or not?
Once profit taker has finish look for CERC to skyrocket in after hours.
$3+ in a/h most likely....or sooner
Shorts covering too.....bigtime!
Good post! > moving up strong!
That big acquisition this month is paying odd! Hedge funds loading.
CERC Double weeeeeeeeeeeeeeeeee, weeeeeeeeeeeeeeeeee huge squeeze here
* * $CERC Video Chart 11-27-17 * *
Link to Video - click here to watch the technical chart video
CERC MONSTER$$$$$$$$$$$$$ . ALERT!!!!!!!!!!! STRONG BUY BUY BUY
BIG NEWS IMMINENT............"We believe CERC-611 has the potential to provide a true advancement in epilepsy therapy," said Uli Hacksell Ph.D., Cerecor's CEO, President and Chairman. "We anticipate filing an investigational new drug application with the United States Food and Drug Administration and thereafter commence Phase 1 development of CERC-611 in 2017."
http://ir.cerecor.com/press-releases/detail/28/discovery-of-cerecor-drug-candidate-cerc-611-ly3130481
BUY ALERT!-(CERC) Major Shareholder Acquires $8296377 Stock at market look 8k today Bullish
* * $CERC Video Chart 10-03-17 * *
Link to Video - click here to watch the technical chart video
"We anticipate filing an investigational new drug application with the United States Food and Drug Administration and thereafter commence Phase 1 development of CERC-611 in 2017."
http://ir.cerecor.com/press-releases/detail/28/discovery-of-cerecor-drug-candidate-cerc-611-ly3130481
big news imminent$$$$
Whatever happened to this board. CERC got a big help and nothing happened with the stock. Hoping for some big moves here SOON!!!!!!
Very nice !!!!
ciao ice big news imminent?
BUY ALERT!-(CERC) Major Shareholder Acquires $8296377 Stock at market August 29 2017 look 8k today Bullish
https://www.dispatchtribunal.com/2017/08/29/cerecor-inc-cerc-major-shareholder-acquires-82963-77-in-stock.html
thanks . very niceeeee$$$$$$
Zacks=Our valuation currently stands at $1.50. CERC
CERC: Sells CERC-501 for $25 Million; Company Currently Trading Below Cash Value
Zacks Small Cap Research
By David Bautz, PhD
Conclusion and Valuation
Following disappointing clinical results for both CERC-301 and CERC-501, the company is looking to “start anew” with a large amount of cash, a renewed focus on the pipeline, and the hiring of a new CEO. We are looking forward to learning more about the use of CERC-301 in orphan neurological indications, and what those indications might be. We anticipate the company moving ahead with an investigational new drug (IND) application for CERC-611 to begin development as an adjunctive treatment for seizures in patients with epilepsy, and additional details about the clinical path forward after that occurs. We anticipate CERC-406 is at least a couple of years away from the clinic as it is still early in preclinical development.
We estimate Cerecor currently has approximately $28 million in cash and a market cap of approximately $15 million. We see no reason the stock should be trading below cash, and CERC-611 has some intriguing preclinical data to support its development as a treatment for seizures. Our valuation currently stands at $1.50.
http://scr.zacks.com/News/Press-Releases/Press-Release-Details/2017/CERC-Sells-CERC-501-for-25-Million-Company-Currently-Trading-Below-Cash-Value-article/default.aspx
Anybody thinking this will take another positive move? I like the news on it.
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
216
|
Created
|
12/05/16
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |